TNF and rheumatoid arthritis: Therefore, the aim of the present study was to compare the effectiveness and safety at 6 months of TCZ in combination with either MTX or LEF in the treatment of patients with active RA and an inadequate response to anti-TNF agents or traditional DMARDs in an observational setting.